2016 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.




Endologix Appoints Prof. Matthew Thompson as Chief Medical Officer

October 25, 2016 -- Endologix, Inc. announced the appointment of Matthew Thompson, MD, as Chief Medical Officer effective December 2016. He succeeds David Deaton, MD, who will…

Veryan Medical Completes Enrollment in MIMICS-2 Study

October 24, 2016 -- Veryan Medical Ltd. announced the completion of patient enrollment in the MIMICS-2 clinical study of its BioMimics three-dimensional (3D) self-expandi…

Medtronic Receives Clearance for Lower-Profile HawkOne 6-F Directional Atherectomy System

October 24, 2016 -- Medtronic plc announced US Food and Drug Administration 510(k) clearance for its HawkOne directional atherectomy system in a new 6-F size to provide a…

Vascular Solutions Fluent Inflation Device Receives FDA Clearance

October 21, 2016 -- Vascular Solutions, Inc. announced that it has received 510(k) clearance from the US Food and Drug Administration for the Fluent inflation device for use d…

DESappear Trial Commences for Akesys Medical’s Prava Scaffold With Elixir Medical’s Bioresorbable Technology

October 20, 2016 -- Akesys Medical announced the successful implantation of the Prava sirolimus-eluting bioresorbable peripheral scaffold system for the treatment of blockages…

Fifteen-Year Follow-Up Data From UK EVAR 1 Trial Published

October 20, 2016 -- Fifteen-year follow-up data from the landmark randomized controlled United Kingdom endovascular aneurysm repair trial 1 (EVAR 1) were published b…

Click here for more News coverage

Current Supplement


The ISR Treatment Paradigm

Defining the best way to approach femoropopliteal in-stent restenosis.

Current European Supplement

Sponsored by Spectranetics

Evidence From the Next-Generation DCB

More With Less

Featured Video

Sponsored by Intact Vascular

Addressing Post-PTA Dissections with a Unique and Novel Approach

Featured Center




Vascular Market Price  Change
Abbott Laboratories $40.19  -0.54%
AstraZeneca PLC $29.79  -0.96%
Avinger $4.08  -5.12%
Boston Scientific Corporation $22.44  -2.31%
Cardinal Health $74.91  -0.93%
Cardiovascular Systems Inc. $22.54  -3.34%
CR Bard Inc. $214.94  -1.82%
Edwards Lifesciences Corp. $113.68  -2.86%
Endologix Inc. $11.92  -4.56%
Johnson and Johnson $113.96  0.31%
Vascular Market Price  Change
Lombard Medical, Inc. $0.86  -3.26%
Medtronic, Inc. $82.47  -1.00%
Merit Medical Systems, Inc. $23.10  -1.28%
Penumbra, Inc. $72.35  -2.10%
St. Jude Medical Inc. $79.01  -0.52%
Stryker $113.19  -1.34%
The Medicines Company $36.97  -0.03%
The Spectranetics Corporation $23.45  -2.09%
Vascular Solutions Inc. $48.17  -0.95%


Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.